FNC
BIO icon

First National Corp’s Bio-Rad Laboratories Class A BIO Stock Holding History

First National Corp’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-17
Closed -$5K – 169
2019
Q1 		$5K Buy
+17
New +$4.59K ﹤0.01% 378

Other funds holding BIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
EIP
Easterly Investment Partners Beverly, Massachusetts $1.31B AUM 18.17% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

First National Corp's BIO Position: Q2 2019 in Review

First National Corp sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2019, closing a stake of 17 shares — an estimated $5K sold.

First National Corp first reported a position in BIO in Q1 2019 and held it in 1 quarter. The position peaked at $5K in Q1 2019. 330 funds tracked by Wall St. Rank hold BIO as of Q2 2019.

  • First National Corp reported no remaining Bio-Rad Laboratories Class A position as of Q2 2019 after selling out during the quarter.
  • First National Corp sold 17 Bio-Rad Laboratories Class A shares in Q2 2019, an estimated $5K.
  • First National Corp first reported a position in Bio-Rad Laboratories Class A in Q1 2019 and held it in 1 quarter.
  • First National Corp's Bio-Rad Laboratories Class A position peaked at $5K in Q1 2019.
  • 330 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2019.

Based on First National Corp's 13F filing for Q2 2019, filed 30 Jul 2019.